Azenta Inc at UBS Global Healthcare Conference Transcript
So my name is Liza Garcia. I'm an analyst at the UBS Life Science Tools Diagnostics Group. And it is my pleasure to welcome Mr. Lindon Robertson, the CFO of Azenta, who will be giving a presentation.
Just very quickly before that, I do have to provide disclosures as an analyst at UBS with regards to my role and that of UBS. You can find the disclosures at ubs.com/disclosures.
And with that, please begin the presentation.
That's great, Liza. Thank you very much, and thank you for everybody tuning in with us and appreciate the interest and attention. The UBS conference has been really good to us over the years. We appreciate the invitation again.
One more disclosure note. Of course, we have the safe harbor statement that we'll abide by, and we'll be making forward-looking statements. And we don't have the obligation to update those until into the future. So please take note that those are forward-looking statements as we talk.
The agenda today is I'm going to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |